Maturation of dendritic cells with immune response modifying compounds
US6558951B1 · kind B1 · utility
206Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 1999 |
| Grant date | May 6, 2003 |
| Priority date | — |
| Expiry date | Feb 11, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inducing the maturation of dendritic cells by stimulating immature dendritic cells with an imidazoquinoline type immune response modifying compound. Dendritic cells that have been matured in this manner display increased antigen presenting ability and may be used as immunotherapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.